BIOMILQ
Biotechnology ResearchNorth Carolina, United States2-10 Employees
BIOMILQ is a biotechnology research company based in Durham, North Carolina, employing a small team of 2 to 10 people and described as women-owned and science-led. The company focuses on mammary biotechnology, using patented technology to produce functional components of human milk through cell culture outside the body. Its stated aim is to bridge the gap between breast milk and infant formula and to broaden access to the benefits of breast milk for more babies. In October 2021, Novo Holdings led a US$21 million Series A financing. A January 2025 report indicated BIOMILQ filed for bankruptcy amid an intellectual property dispute.